Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed2
Recruiting1
Terminated1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT01526603Not ApplicableCompleted
High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
Neuroblastoma
PrincipalinvestigatorStart date: 2012-03-28
NCT01505569Not ApplicableCompleted
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Atypical Teratoid/Rhabdoid Tumor (AT/RT)CNS TumorsEwing's Family Tumors+9 more
PrincipalinvestigatorStart date: 2011-10-20
NCT02179359Not ApplicableTerminated
Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
Diamond Blackfan AnemiaGlanzmann ThrombastheniaNon-Malignant Hematologic Disorders+5 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02605421Phase 2PrincipalInvestigator

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

Neuroblastoma
Recruiting
NCT01526603Not ApplicablePrincipalInvestigator

High Dose Chemotherapy and Autologous Transplant for Neuroblastoma

Neuroblastoma
Completed
NCT01505569Not ApplicablePrincipalInvestigator

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Atypical Teratoid/Rhabdoid Tumor (AT/RT)CNS TumorsEwing's Family Tumors+9 more
Completed
NCT02179359Not ApplicablePrincipalInvestigator

Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

Diamond Blackfan AnemiaGlanzmann ThrombastheniaNon-Malignant Hematologic Disorders+5 more
Terminated

All 4 trials loaded